Vis enkel innførsel

dc.contributor.authorIversen, Per Ole
dc.contributor.authorFrøyland, Livar
dc.contributor.authorHaugen, Margaretha
dc.contributor.authorHolvik, Kristin
dc.contributor.authorLøvik, Martinus
dc.contributor.authorStrand, Tor A
dc.contributor.authorTell, Grethe S.
dc.coverage.spatialNorwaynb_NO
dc.date.accessioned2018-04-27T11:38:29Z
dc.date.available2018-04-27T11:38:29Z
dc.date.created2017-10-19T09:53:03Z
dc.date.issued2016
dc.identifier.isbn978-82-8259-196-6
dc.identifier.urihttp://hdl.handle.net/11250/2496381
dc.description.abstractThe Norwegian Scientific Committee for Food Safety (VKM) has, at the request of the Norwegian Food Safety Authority, assessed the risk of specified doses of CLAs in food supplements. VKM concludes that: • In adults (≥18 years), the specified doses 3.0, 3.25 and 3.5 g/day CLAs in food supplements are considered to be unlikely to cause adverse health effects if used for up to six months. • CLA may cause lipid- and carbohydrate disturbances in obese men with metabolic syndrome as well as in overweight/obese subjects with type 2 diabetes. • Use of CLA supplements in lactating and pregnant women may cause reduction in milk production and in the content on milk fat and cause decreased birth weight andlength in their off-springs. • No conclusion can be made for children and adolescents. • Data are insufficient to conclude regarding use of CLAs for more than six months.nb_NO
dc.language.isoengen
dc.publisherNorwegian Committee for Food Safety (VKM)en
dc.relation.ispartofVKM Report
dc.relation.ispartofseriesVKM Report;
dc.relation.urihttps://vkm.no/download/18.645b840415d03a2fe8f2602a/1502797996894/e5f72e01ec.pdf
dc.rightsNavngivelse-Ikkekommersiell-DelPåSammeVilkår 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/deed.no*
dc.subjectAdverse health effectnb_NO
dc.subjectCLAnb_NO
dc.subjectconjugated linoleic aciden
dc.subjectfood supplementen
dc.subjectnegative health effecten
dc.subjectNorwegian Scientific Committee for Food Safetyen
dc.subjectother substancesen
dc.subjectrisk assessmenten
dc.subjectVKMen
dc.titleRisk assessment of "other substances" - conjugated linoleic acids. Opinion of the Panel on Nutrition, Dietetic Products, Novel Food and Allergy of the Norwegian Scientific Committee for Food Safetyen
dc.typeOthersen
dc.description.versionpublishedVersionnb_NO
dc.source.pagenumber82nb_NO
dc.source.issue5nb_NO
dc.identifier.cristin1505791
cristin.unitcode1991,0,0,0
cristin.unitnameSykehuset Innlandet HF
cristin.ispublishedtrue
cristin.fulltextoriginal


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse-Ikkekommersiell-DelPåSammeVilkår 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse-Ikkekommersiell-DelPåSammeVilkår 4.0 Internasjonal